Last Updated on October 6, 2024 by The Health Master
New Delhi: Zydus Lifesciences Ltd said it has received final approval from the US health regulator to manufacture and market its generic Indomethacin suppositories indicated for moderate to severe rheumatoid arthritis.
The approval by the US Food and Drug Administration (USFDA) is for the manufacturing and marketing of Indomethacin suppositories of 50mg strength, the company said in a regulatory filing.
The company has been granted 180-day CGT (competitive generic therapy) exclusivity to market this product, it added.
As per the USFDA, it may designate a drug as a CGT after determining that there is inadequate generic competition for that drug.
“We are happy to leverage the CGT approval pathway of the USFDA to provide patients with expanded access to a product with limited competition,” Zydus Lifesciences Managing Director Dr. Sharvil Patel said.
Zydus said Indomethacin suppositories is a non-steroidal, anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis), and acute gouty arthritis.
Citing IQVIA MAT April 2023 data, the company said Indomethacin suppositories 50mg had annual sales of approximately USD 95 million in the US.
Lupin gets USFDA nod to market generic skin treatment medication
USFDA gives approval for Saxagliptin Tablets
USFDA gives approval for Saxagliptin Tablets
USFDA gives marketing approval for this Birth Control Pill
USFDA gives nod to market this cancer treatment generic injection
Govt extends implementation date for Track and Trace System in Drug Exports
Stakeholders urge Govt to recall New Drugs, Cosmetics & Medical Devices Bill
Gujarat FDCA takes stringent actions against Non-Compliant Pharma Companies
Legal Metrology Division urges to ensure compliance of Rules 26 on…
Major Crackdown: Rs 2 Crore-worth counterfeit drugs seized in Kolkata
Positive Govt response awaited for New Regulation on OTC Drugs
Quality Assurance in the Pharmaceutical Industry
Drug Dept cautions consumers about 15 NSQ drugs in circulation: Karnataka
Govt prohibits Ketoprofen and Aceclofenac formulations for Animal Use
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
